Observed Signal · Jul 2, 2026 · Industry Commentary · Source: The Drum · Impact: 2/5 · Sentiment: Positive
Pharma as Model for AI in Regulated Marketing
At Cannes Lions, Tom Richards (global chief creative officer at 21GRAMS, part of Real Chemistry) and Camilla Griffiths (president for Europe at 21GRAMS) told The Drum that the pharmaceutical sector offers a useful blueprint for marketing with AI under tight regulation. They argue that regulatory constraints can sharpen creative briefs and that involving compliance, legal and regulatory teams from the start produces better work. They also warn that AI changes how audiences discover health information — calling AI “an audience in and of itself” — and that brands must prioritise trustworthy, useful guidance to help empowered patients navigate conflicting online advice. The pair suggest healthcare’s regulated experience can help other industries adapt to AI, trust and scrutiny in marketing.
Provides industry insight showing how heavily regulated sectors (pharma) can serve as a practical blueprint for marketers using AI under tightened regulation; useful but not industry-shifting.
Track Real-Time Regulation Signals & Market Shifts
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Tom Richards is global chief creative officer at 21GRAMS (part of Real Chemistry).
- Camilla Griffiths is president for Europe at 21GRAMS.
- At Cannes Lions they said pharma can be a 'poster boy' for working with AI under regulation.
- They recommend involving compliance, legal and regulatory teams from the beginning of healthcare campaigns.
- They described AI as 'an audience in and of itself' and urged brands to provide trustworthy information as patients become more empowered.
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Cannes: AI Search Crisis Is Really Brand Coherence
At Cannes Lions 2026, industry conversations shifted from creative execution to how brands appear, are trusted, and recommended by LLMs and AI-driven search systems. Speakers and executives argued that large language models synthesize signals from SEO, PR, content and product pages into a single, machine-read ‘truth,’ exposing inconsistencies across functions. Practitioners say the challenge is coordination and organisational change — not just SEO tactics — because LLMs prioritise machine-readable authority, citations and trust signals. Boston Consulting Group data cited at the festival found 96% of 300 CMOs believe AI is transforming marketing, but only about a third have rebuilt workflows or operating models. Panelists urged governance, cross-functional alignment, and new measurement approaches so brands can be both persuasive to people and legible to AI systems.
Healthcare Marketing Embraces Agile Omnichannel and AI
At an Adweek House Cannes panel co-hosted with Doceree, healthcare marketing leaders discussed the need to move beyond traditional, linear planning toward more responsive, agile omnichannel frameworks. Panelists — including executives from Doceree, Publicis Health Media, Good Apple, Real Chemistry Media, Digitas Health and Novo Nordisk — argued that annual plans and vanity metrics (clicks, impressions) are insufficient for evolving provider and patient journeys. They emphasized aligning content strategies for prescribers and consumers, granting greater organizational and agency autonomy to speed decision-making, and incorporating AI tools to accelerate creative cycles and better predict future patient and provider behavior. The conversation highlighted rising importance of intent measurement in prescription decisions and the convergence of provider and patient content strategies.
Brands Set Rules for AI in Customer-Facing Content
Brands are rapidly adopting generative AI to accelerate creative production, remix existing assets, lower costs and enable concepts impractical to film, while enforcing brand-specific guardrails for consumer-facing content. Case studies from Unilever, Hilton, Koia, Coca‑Cola and smaller brands show faster asset turnaround and measurable performance gains, but marketers emphasize AI should refine—not replace—human creativity to avoid “sameness,” authenticity risks and potential consumer backlash. Teams distinguish behind-the-scenes uses (drafting, optimization, localization) from visible AI outputs (AI-generated people), with some brands limiting public-facing AI to protect trust or premium positioning. Surveys underline near-universal marketer adoption—Canva found most leaders use AI daily and plan to increase investment—so companies pair AI-driven scale with policies and creative oversight to preserve brand voice.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.